Project Grant HT94252510590
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$705K
Federal Agency
Defense Health Agency
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
The Department of the Army Medical Command awarded Yale University a $1,304,470.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on July 1, 2025, supports the "DEVELOPMENT OF GUAR-T AS A NOVEL CLASS OF UNIVERSAL CELLULAR IMMUNOTHERAPIES FOR OVARIAN CANCER" over a performance period ending on June 30, 2029. This research project aims to develop a novel class of universal cellular immunotherapies for the...
This $1,004,472.00 Project Grant was awarded on June 15, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports Yale University in conducting advanced biomedical research on mast cell therapy for ovarian cancer. The research aims to transform healthcare for military service members and the broader public by developing innovative approaches to disease prevention, diagnosis, treatment, and management of...
This $1,005,000.00 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research on mast cell therapy for ovarian cancer at Yale University. The award, with a period of performance from June 15, 2025 to June 14, 2029, will fund advanced biomedical research focused on transforming healthcare for military service members and the broader public. The grant supports Yale University's work in...
The Defense Health Agency awarded Yale University a $3,129,087.00 Project Grant on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced research to develop integrative platforms for cellular immunotherapies against resistant hematopoietic malignancies and solid tumors. Key aims include targeting combinations of gene editing and CAT inhibition to enhance CAR-T cell function, and investigating gene editing coupled with CAT...
This Project Grant award from the Defense Health Agency, through the Military Medical Research and Development program (CFDA 12.420), provides $514,335 to Yale University to optimize adoptive cellular immunotherapy for rare melanomas. The award began on September 1, 2023 and is scheduled for completion on August 31, 2026. The research aims to transform health care for service members and the American public through innovative and impactful medical solutions, with a focus on developing treatments...
The Defense Health Agency has awarded a $1,674,999.00 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). The grant is for the "PERTURBOMICS IDENTIFICATION OF CRITICAL GENETIC TARGETS IN NK CELLS FOR BREAST CANCER THERAPY" project, which will be conducted from September 1, 2023 to August 31, 2026. The funding will support basic, applied, and advanced biomedical research to transform healthcare for service members and the public...
This federal Project Grant award of $837,497.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research by Yale University to investigate "FEEDING STRESS PRIMES THE PANCREAS FOR CANCER" with a performance period from November 1, 2024 to October 31, 2027. The research aims to transform healthcare for military service members and the broader public by exploring innovative...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,130,469 to Yale University to uncover the tumor-immune microenvironmental determinants of immunotherapy response in renal cell carcinoma through ex vivo patient-derived models. The research aims to transform health care for Service Members and the American public through innovative and impactful research investigating medical solutions for the battlefield....
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
This $1,305,270 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports the "Ovarian Cancer Academy: Advancing Ovarian Cancer Research through Mentorship, Networking, and Collaborations" initiative led by The Trustees of the University of Pennsylvania. The award aims to transform healthcare for military service members and the general public through innovative biomedical research in...